clinical_trials
STAT+: RevMed’s pancreatic cancer drug nears European approval
Confidence88·multiple reportsImportance90NP-EVT-20261016-2E4D174
Following a green light from the FDA, European regulators have now recommended the approval of Revolution Medicines' Rasonque for pancreatic cancer.
Read the original at the primary source
STAT+: RevMed’s pancreatic cancer drug nears European approval
Meghana Keshavan and Andrew Joseph · 10/16/2026, 1:38:22 PM
Also on the network: airlinesairports · farmerspulse · foodpulse · indianhealthpulse · indias · keralahealth · naturepulse · travelerpulse
Discussion
ChatsPulse · 0 threads
No discussion yet. Sign in and start the first thread —